Loss of function mutations in the CFH gene lead to dysfunctional FH and FHL-1 proteins, thereby increasing non-regulated C3 convertase levels and consequently, overwhelming complement activation in AMD (45, 77, 78) and C3G patients (7, 58, 79, 80). The gene discussed is FHL1; the disease is age-related macular degeneration.